Graft fixation

Abstract
The present disclosure relates to an anchor for fixating a tissue graft to bone. The anchor includes a through hole extending an entire length of the anchor and a polymer composition having shape memory qualities. Other anchors and methods for fixating a tissue graft to bone are also disclosed.
Description
BACKGROUND

1. Field of the Invention


The present disclosure relates generally to tissue graft fixation and, more particularly, to tissue graft fixation via the use of shape memory polymer material.


2. Related Art


A ligament, such as an anterior cruciate ligament (ACL), that has ruptured and is non-repairable, is generally replaced arthroscopically by a tissue graft. The tissue graft may be harvested from a portion of a patellar tendon having so called “bone blocks” at each end, and from the semitendonosis and gracilis. Alternatively, the tissue graft can be funned from synthetic materials or from a combination of synthetic and natural materials.


The replacement tissue graft is implanted by securing one end of the tissue graft in a socket formed in a passage within the femur, and passing the other end of the graft through a passage formed in the tibia. Generally, sutures arc used to affix each end of the tissue graft to a fastener (e.g., an interference screw or a post), which is then secured to the bone. The use of a fastener, such as an interference screw, may create complications for several reasons: the possibility of the screw threads damaging the grafts during screw installation if the screw is too big in relation to the graft and/or if the space between the passage and the grafts is too small, the graft rotating with the screw during screw installation so that the optimal position of the grafts is lost and/or the grafts are damaged, divergence of the grafts and/or screw occurring, the requirement of a range of fastener sizes for different patients, and, if the screw is non-metal, the possibility of the screw breaking during insertion.


SUMMARY

In one aspect, the present disclosure relates to an anchor for fixating a tissue graft to bone. The anchor includes a through hole extending an entire length of the anchor. The anchor includes a polymer composition including shape memory qualities. In an embodiment, the through hole is circular, star-shaped, or rectangular. In another embodiment, the anchor further includes a component disposed within the through hole of the anchor, wherein the component includes a polymer composition having shape memory qualities. In yet another embodiment, the through hole is divided into two sections. In a further embodiment, the through hole is divided into four sections.


In another aspect, the present disclosure relates to an anchor for fixating a tissue graft to bone. The anchor includes a first groove extending an entire length of the anchor and a second groove extending an. entire length of the anchor. The anchor includes a polymer composition. having shape memory qualities. In an embodiment, the first groove and the second groove both include barbs.


In yet another aspect, the present disclosure relates to an anchor for fixating a tissue graft to bone. The anchor includes a cross-section in a shape of a cross and a polymer composition including shape memory qualities.


In a further embodiment, the present disclosure relates to an anchor for fixating a tissue graft to bone. The anchor includes a body having a curved top portion, a curved bottom portion, and two sides located between the top portion and the bottom portion. In an embodiment, the sides are curved inward toward the body of the anchor.


In yet a further embodiment, the present disclosure relates to a method of fixating a tissue graft to bone. The method includes providing an anchor having a through hole extending an entire length of the anchor. The anchor includes a polymer composition having shape memory qualities; inserting an end of a tissue graft into the through hole; inserting the anchor into a bone tunnel; providing the anchor with energy to deform the anchor and fixate the graft within the bone tunnel.


In an embodiment, the method further includes a component disposed within the through hole, the component including a polymer composition having shape memory qualities. In another embodiment, the through hole is divided into two sections, wherein the method further includes inserting ends of a tissue graft into the sections. In yet another embodiment, the through hole is divided into the four sections, wherein the method further includes inserting ends of multiple tissue grafts into the sections.


In an embodiment, the present disclosure relates to a method of fixating tissue grafts to bone. The method includes providing at least two tissue grafts; coupling the at least two tissue grafts; inserting the at least two tissue grafts into a bone tunnel; inserting an anchor into the bone tunnel such that the anchor is located between the at least two tissue grafts; and providing energy to the anchor to deform the anchor and fixate the at least two tissue grafts within the bone tunnel.


Further features, aspects, and advantages of the present disclosure, as well as the structure and operation of various embodiments of the present disclosure, are described in detail below with reference to the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated in and form a part of the specification, illustrate the embodiments of the present disclosure and together with the description, serve to explain the principles of the disclosure. In the drawings:



FIGS. 1A and 1B show a cross-sectional view of an end of a tissue graft disposed within an anchor of a first embodiment of the present disclosure both before and after deformation of the anchor.



FIGS. 2A and 2B show cross-sectional views of an anchor of a second embodiment of the present disclosure before and after deformation of the anchor.



FIGS. 2C and 2D show cross-sectional views of an anchor of a third embodiment of the present disclosure before and after deformation of the anchor.



FIGS. 2E and 2F show cross-sectional views of an anchor of a fourth embodiment of the present disclosure before and after deformation of the anchor.



FIGS. 3A and 3B show cross-sectional views of an end of a tissue graft disposed within an anchor of a fifth embodiment of the present disclosure before and after deformation of the anchor.



FIGS. 4A and 4B show cross-sectional views of an anchor of a sixth embodiment of the present disclosure before and after deformation of the anchor.



FIGS. 5A and 5B show cross-sectional views of an anchor of a seventh embodiment of the present disclosure before and after deformation of the anchor.



FIGS. 6A and 6B show cross-sectional views of an anchor of an eighth embodiment of the present disclosure before and after deformation of the anchor.



FIGS. 7A and 7B show cross-sectional views of a bone tunnel having surface features on walls of the tunnel.



FIG. 8A shows a side view of an anchor of a ninth embodiment of the present disclosure



FIG. 8B shows a cross-sectional view of the anchor of FIG. 8A.



FIG. 8C shows a front view of the anchor of FIG. 8A.



FIG. 9 shows a cross-sectional view of the anchor of FIG. 8A in a bone tunnel and after deformation of the anchor.



FIG. 10 shows mechanical testing data for the anchor of the present disclosure.



FIGS. 11A and 11B show a method of fixating tissue grafts within a bone tunnel using an anchor of the present disclosure.





DETAILED DESCRIPTION OF THE EMBODIMENTS


FIGS. 1A and 1B show cross-sectional views of a cylindrical anchor 10 with a central through hole 11 into which an end 12a of a tissue graft 12 is placed. The anchor 10 is then loosely press fit into a pre-formed passage 13a in bone 13, such as a femoral passage in a femur, as described above. Upon providing the anchor 10 with energy, the anchor 10 expands radially and shrinks axially, as shown by arrows in FIG. 1B, thereby fixating the tissue graft 12 and anchor 10 to the bone 13.


Alternative embodiments of the anchor 10 include those shown in FIGS. 2A, 2C, and 2E, which are similar to the anchor described above except that the through holes 11 include those shaped as a star (FIG. 2A), a slot (FIG. 2C), and a toothed slot (FIG. 2E). FIGS. 2B, 2D, and 2F show the anchors 10 of FIGS. 2A, 2C, and 2E, respectively, after the anchors 10 arc provided with energy. Other shapes for the through holes 11 are also within the scope of this disclosure. It is believed that having a through hole with the shapes shown in FIGS. 2A, 2C, and 2E would increase the fixation of the graft to the anchor due to an increase in the amount of surface area and points of contact engaging the graft. The number of holes 11 in the anchor 10 may vary.


The anchor comprises polymeric shape memory material. Shape memory polymers, which can be resorbable or non-resorbable, are known in the art and any biocompatible polymeric shape memory material can be used in the context of the present disclosure. Specific polymers that may be used include polyetheretherketone (PEEK), polymethyl methacrylate (PMMA), polyethyl methacrylate (PTMA), polyacrylate, poly-alpha-hydroxy acids, polycaprolactones, polydioxanones, polyesters, polyglycolic acid, polyglycols, polylactides, polyorthoesters, polyphosphates, polyoxaesters, polyphosphoesters, polyphosphonates, polysaccharides, polytyrosine carbonates, polyurethanes, and copolymers or polymer blends thereof.


The anchor 10 may be formed by a process that would provide the anchor 10 with shape memory properties, such as, without limitation, zone drawing, hydrostatic extrusion, die drawing, compression flow molding, thermoforming, rolling, and roll drawing. The through hole 11 may be formed in the anchor 10 while it is being manufactured. Alternatively, the through hole 11 may be formed in the anchor 10 post processing by drilling or by any other method of forming the through hole 11.


Generally, polymers that display shape memory qualities show a large change in modulus of elasticity at the glass transition temperature (Tg). The shape-memory function can be achieved by taking advantage of this characteristic. Namely, a molded article (primary molded article) to which a definite shape (the original shape) has been imparted by a common method for molding plastics, is softened by providing the article with energy and heating to a temperature (Tf) higher than the Tg of the polymer, but lower than the melting temperature (Tm) thereof so as to deform it into a different shape. Next, the molded article is cooled to a temperature lower than the Tg, while maintaining the thus deformed shape (secondary molded article). When it is heated again to a temperature higher than the secondary molding temperature Tf, but lower than the Tm, the shape of the secondary molded article disappears and thus the article is recovered to the original shape of the primary molded article.


For the purposes of this disclosure, a molded article (i.e. the above-mentioned anchor), having a definite shape (original shape) is formed from polymer material and is provided with energy to heat the article to a temperature above the glass transition temperature of the polymer, but lower than the melting temperature (Tm thereof so as to deform it into a different shape and effectively wedge the article between the tissue graft and the bone. In this manner, the tissue graft becomes fixed to the bone. However, for the purposes of this disclosure, rather than cooling the anchor and heating it again until it recovers its original shape, the anchor is kept in this deformed shape so as to maintain fixation of the tissue graft to the bone. The glass transition temperature of the polymer material will vary based on a variety of factors, such as molecular weight, composition, structure of the polymer, and other factors known to one of ordinary skill in the art.


Examples of adding energy to the polymer material include electrical and thermal energy sources, the use of force, or mechanical energy, and/or a solvent. Examples of thermal energy sources include a heated liquid, such as water or saline. It is also within the scope of this disclosure that once the anchor 10 is placed in the bone, body heat would be transferred from blood and tissue, via thermal conduction, to provide the energy necessary to deform the shape memory polymer material. In this instance, body temperature would be used as the thermal energy source. Examples of electrical energy sources include heat generating devices such as a cauterizing device or insulated conductor, as more fully described in PCT Application No. PCT/US2008/056828, the disclosure of which is incorporated herein by reference in its entirety, or a heating probe, as more fully described in PCT Application No. PCT/US2008/056836, the disclosure of which is incorporated herein by reference in its entirety. For instance, the anchor 10 may include a hole in the body of the anchor 10 that a heating device, such as the heating probe described above, may be inserted into.


Any suitable force that can be applied either preoperatively or intra-operatively can be used as a form of energy. One example includes the use of ultra sonic devices, which can relax the polymer material with minimal heat generation. Solvents that could be used as the form of energy include organic-based solvents and aqueous-based solvents, including body fluids. Care should he taken that the selected solvent is not contra indicated for the patient, particularly when the solvent is used intra-operatively. The choice of solvents will also be selected based upon the material to be relaxed. Examples of solvents that can be used to relax the polymer material include alcohols, glycols, glycol ethers, oils, fatty acids, acetates, acetylenes, ketones, aromatic hydrocarbon solvents, and chlorinated solvents.


A further embodiment of the anchor is shown in FIGS. 3A and 3B. The anchor 20 includes a through hole 21 and a component 22 disposed within the through hole 21. Multiple grafts 23 can be placed into the through hole 21 along with the component 22, which, as shown in FIG. 3B, decreases in length and increases in diameter, similar to anchor 20, thereby providing further fixation of the grafts 23 to anchor 20 and therefore the bone 24. The anchor 20 and component 22 may be formed by a process that would provide the anchor 20 and component 22 with shape memory properties, such as, without limitation, zone drawing, hydrostatic extrusion, die drawing, compression flow molding, thermoforming, rolling, and roll drawing. The through hole 21 may be formed in the anchor 20 while it is being manufactured. Alternatively, the through hole 21 may be formed in the anchor 20 post processing by drilling or by any other method of forming the through hole 21.


Another embodiment is shown in FIGS. 4A-4B, 5A-5B, and 6A-6B. The anchor 30 of FIG. 4A includes a through hole 31 that is divided into four separate openings 31a-31d allowing the possibility of up to four tissue graft ends being fixated to the anchor 30 when the anchor 30 is provided with energy, as shown in FIG. 4B. FIGS. 5A-5B show an. anchor 40 having two grooves 41, both of which may extend the entire length of the anchor 40 or a partial length. Surfaces 41a of the grooves 41 include features, such as barbs 41a′, which may allow further fixation of the anchor 40 to the graft upon providing the anchor 40 with energy, as shown in FIG. 5B. FIGS. 6A-6B show an anchor 50 in the shape of a cross. Similar to the anchor 30 of FIGS. 4A-4B, anchor 50 allows for the possibility of four tissue graft ends being fixated to the anchor 50 when the anchor 50 is provided with energy, as shown in FIG. 6B.


The anchors 40,50 of FIGS. 5A and 6A expand to cause an interference fit against walls 42a,52a of the bone tunnels 42,52, thereby not only fixating the anchors 40,50 to the walls 42a,52a, but also fixating tissue graft ends to the bone 43,53, which allow direct osseointegration of the graft to the walls 42a,52a. The anchors 30, 40, 50 may be formed by a process that would provide the anchors 30, 40, 50 with shape memory properties, such as, without limitation, zone drawing, hydrostatic extrusion, die drawing, compression flow molding, thermoforming, rolling, and roll drawing. The through hole 31, openings 31a-31d, grooves 41, and barbs 41a′ may be formed in the anchors 30, 40 while it is being manufactured. Alternatively, these features may be formed in the anchors 30,40 post processing by drilling or by any other method.


As shown in FIGS. 7A and 7B, the walls 61a may include surface features 62, such as barbs and/or spikes, which would allow more integration of the anchor 60 into the bone 63 upon providing the anchor 60 with energy, thereby increasing fixation of the anchor 60, and therefore a graft, to the bone 63. The surface features 62 may be made via the use of a mechanical tool or other devices known to one of skill in the art for making the features 62.


In an embodiment shown in FIGS. 8A-8C, an anchor 70 has been shaped to aid insertion into a bone tunnel containing ligaments or bone block, as will be further described below. The anchor 70 includes substantially rounded top and bottom portions 71,72 and two sides 73,74, located between the top and bottom portions 71,72, both of which are configured to house graft ends when the plug is disposed within a hone tunnel, as will be further described below. The anchor 70 also includes a tapered front portion 75, an angled back portion 76, and an opening 77 that partially extends a length of the anchor 70. The opening 77 is configured for engagement with a delivery device for delivery of the anchor 70 into a bone tunnel, as will be further described below.


In use, as shown in FIG. 9, the anchor 70 is inserted into a bone tunnel 78, via the use of a delivery device, as mentioned above, such that the graft ends 79 extend along the sides 73,74 of the anchor 70. The anchor 70 is then provided with energy, via the use of one of the heating devices described above, by inserting the heating device into the opening 77 and activating it, thereby resulting in the anchor 70 expanding to compress the graft ends 79 against the bone tunnel wall 78a and fixate the plug 70 and the graft ends 79 within the bone tunnel 78. Other energy sources may also be used. The anchor 70 may be of various sizes to accommodate the size of the bone tunnel 78 and substantially increase the possibility of engagement of the anchor 70 and the graft ends 79 with the wall 78a upon deformation of the anchor 70.


The anchor 70 may be formed by a process that would provide the anchor 70 with shape memory properties, such as, without limitation, zone drawing, hydrostatic extrusion, die drawing, compression flow molding, thermoforming, rolling, and roll drawing. Alternatively, the anchor 70 is processed via one of the methods described above and subsequently machined to include the shape of the sides 73,74 and the top and bottom portions 71,72. The opening 77 may be formed in the anchor 70 while it is being manufactured. Alternatively, the opening 71 may be formed in the anchor 70 post processing by drilling or by any other method of forming the opening 71.


EXAMPLE

An 8.5 mm hole was drilled through the centre of a block of 20 pcf sawbone having the following dimensions: 42 mm long, 31 mm wide, and 31 mm thick.


Two pieces of 7 inch long 125 lb braided nylon rope were doubled over and inserted into the hole so that the four ends of rope passed all the way through the hole in the sawbone. An anchor including Poly (D,L lactide-co-glycolide) and calcium carbonate was inserted into the hole ensuring that the strands of nylon rope passing through the hole did not cross over one another and each of the four ends of nylon had its own quadrant of the hole. The anchor was processed via a die drawing process to include shape memory qualities. The ratio of lactide:glyeolidc was 85:15 and the calcium carbonate was present at between about 35.5% by weight of the polymer composition. Once in place, the plug was relaxed by immersion of the block, plug, and rope into hot water (approximately 80° C. for 5 min). When the block containing the plug and rope had cooled to room temperature, it was inserted into an aluminum sleeve having similar dimensions to the sawbone block.


Mechanical testing was carried out using an Instron 5566 with a 10 kN load cell. The aluminum sleeve housing the sawbone block was clamped in a first grip of the Instron and the nylon loops were clamped in a second grip, specifically, the loops were clamped to the crosshead of the Instron. The crosshead was extended until the loops were taut, which, as shown in FIG. 10, occurred when the crosshead was extended 21 mm, and then testing began. Testing was carried out with a crosshead speed of 25 mm/min and a pre-load of 22.3N. As shown in FIG. 10, the plug was found to have a maximum fixation strength of 532 N.


A further embodiment is shown in FIGS. 11A and 11B. In order to substantially reduce the graft ends 80a from slipping between an anchor 90 and the bone tunnel wall 100a, the ends 80a may be coupled at one point via a biocompatible connector 200 including, without limitation, a suture, a clip, or staple. The grails 80 arc placed into a previously drilled hone tunnel 100 and an anchor 90 is then inserted between the grafts 80 and deformed by providing the anchor 90 with energy, as shown in FIG. 11B, to fixate the grafts 80 within the tunnel 100.


The anchor 90 may be formed by a process that would provide the anchor 90 with shape memory properties, such as, without limitation, zone drawing, hydrostatic extrusion, die drawing, compression flow molding, thermoforming, rolling, and roll drawing.


The anchors described above may include a reinforced polymeric material. Preferably, the reinforced polymeric material comprises a composite or matrix including reinforcing material or phases such as fibers, rods, platelets, and fillers. More preferably, the polymeric material can include glass fibers, carbon fibers, polymeric fibers, ceramic fibers, or ceramic particulates. Other reinforcing material or phases known to one of ordinary skill in the art could also be used. One or more material from which the anchor is formed may be porous. Porosity can allow infiltration by cells from surrounding tissues, enhancing integration of the device by processes such as osseointegration.


In addition, one or more actives/agents may be incorporated into the material of the anchor. Suitable actives/agents include bone morphogenic proteins, antibiotics, anti-inflammatories, angiogenic factors, osteogenic factors, monobutyrin, thrombin, modified proteins, platelet rich plasma/solution, platelet poor plasma/solution, bone marrow aspirate, and any cells sourced from flora or fauna, such as living cells, preserved cells, dormant cells, and dead cells. It will be appreciated that other bioactive agents known to one of ordinary skill in the art may also be used. Preferably, the active agent is incorporated into the polymeric shape memory material, to be released during the relaxation or degradation of the polymer material. Advantageously, the incorporation of an active agent can act to combat infection at the site of implantation and/or to promote new tissue growth.


The anchor described above may also include at least one feature, such as protrusions, that arc coupled to a surface of the anchor via a variety of methods, such as an interference fit between the polymer and the protrusions, adhesion of the protrusion to the polymer, or any other method known to one of ordinary skill in the art. In addition, the number of protrusions present on the surface of the anchor may vary. The protrusions may provide multiple contact points to increase the friction between the anchor and the bone, thereby providing increased fixation between the tissue graft and the bone. The protrusions may be selected from a group that includes a metal material, a non-metal material, a polymer material, and combinations thereof and may be of any shape or size. If a polymer material is used for the protrusions, the polymer material may include a resorbable or non-resorbable polymer material.


Use of the protrusions may he eliminated by including a particulate material within or on an outer surface of the anchor. The particulate material may include a ceramic material, a crystalline polymer, or any other type of material that would provide the polymer material with multiple contact points to increase the friction between the polymer material and the bone.


The anchors described above, and especially anchors 10,20, may he biaxially oriented to have an internal diameter that decreases and an external diameter that increases when the anchor is provided with energy. This allows for the internal diameter to further grip the anchor to the tissue graft(s) and the outer diameter to engage the surrounding bone, thereby locking the tissue graft(s) in place. In order to make an anchor of biaxially oriented shape memory polymer material, a rod of shape memory polymer material may be die drawn over a mandrel. Further discussion of this process can he found in U.S. Patent Application Ser. No. 60/912,740, the disclosure of which is incorporated herein by reference in its entirety.


The shape memory anchors of the present disclosure may substantially reduce the need to thrcad/pre-tap the bone tunnel before insertion of the anchor into the bone tunnel, especially when a patellar tendon is used as the tissue graft. In addition, it is believed that the anchor would offer improved fixation over existing systems. Furthermore, the anchors may substantially reduce the possibility of making a range of fasteners to fit the patient, thereby possibly offering a ‘one size fits all’ approach.


In view of the foregoing, it will be seen that the several advantages of the invention are achieved and attained.


The embodiments were chosen and described in order to best explain the principles of the disclosure and its practical application to thereby enable others skilled in the art to best utilize the disclosure in various embodiments and with various modifications as are suited to the particular use contemplated.


As various modifications could be made in the constructions and methods herein described and illustrated without departing from the scope of the disclosure, it is intended that all matter contained in the foregoing description or shown in the accompanying drawings shall be interpreted as illustrative rather than limiting. Thus, the breadth and scope of the present disclosure should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with the following claims appended hereto and their equivalents.

Claims
  • 1. An anchor for fixating a tissue graft to bone, the anchor comprising: an elongated body disposable into a bone tunnel in a bone and made from a shape-memory material, the elongated body comprising:a non-tapered proximal portion, comprising: a first concave outer surface extending longitudinally along the entire non-tapered proximal portion to define a first longitudinal channel along a first side of the elongated body wherein the first concave outer surface has a shape memory configured to compress a first tissue graft end portion against the bone tunnel wall in response to receiving a shape memory activation energy;a first convex outer surface extending longitudinally along an entire second side of the non-tapered portion and configured to engage a bone tunnel wall of the bone when the elongated body is inserted into the bone tunnel; anda tapered distal portion extending longitudinally from the non-tapered proximal portion wherein the-first concave outer surface extends longitudinally along the entire tapered distal portion.
  • 2. The anchor of 1, further comprising a cavity extending longitudinally into the elongated body from a proximal end of the elongated body, the cavity shaped to receive a delivery device and/or a heating device.
  • 3. The anchor of claim 2, wherein the non-tapered proximal portion further comprises: a second concave outer surface extending longitudinally along the entire non-tapered proximal portion to define a second longitudinal channel along a third side of the elongated body opposite the first side of the elongated body wherein the second concave outer surface has a shape memory configured to compress a second tissue graft end portion against the bone tunnel wall in response to receiving the shape memory activation energy; anda second convex outer surface extending longitudinally along an entire fourth side of the non-tapered portion opposite the second side of the non-tapered portion and configured to engage the bone tunnel wall of the bone when the elongated body is inserted into the bone tunnel.
  • 4. The anchor of claim 3, wherein the second concave outer surface extends longitudinally along the entire tapered distal portion.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a U.S. National Stage Application, submitted under 35 U.S.C. 371, claiming priority to PCT International Patent Application PCT/US2008/060401 filed on Apr. 16, 2008, which claims priority to U.S. Patent Application No. 60/912,828 filed on Apr. 19, 2007, the disclosures of which are incorporated herein by reference in their entirety.

PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/US2008/060401 4/16/2008 WO 00 10/8/2009
Publishing Document Publishing Date Country Kind
WO2008/130954 10/30/2008 WO A
US Referenced Citations (325)
Number Name Date Kind
3531561 Trehu Sep 1970 A
3636956 Schneider Jan 1972 A
3736646 Schmitt et al. Jun 1973 A
3797499 Schneider Mar 1974 A
3856905 Dawson Dec 1974 A
3926459 Pontigny Dec 1975 A
4137921 Okuzumi et al. Feb 1979 A
4181983 Kulkarni Jan 1980 A
4438253 Casey et al. Mar 1984 A
4523591 Kaplan et al. Jun 1985 A
4539981 Tunc Sep 1985 A
4559945 Koelmel et al. Dec 1985 A
4636215 Schwartz Jan 1987 A
4700704 Jamiolkowski et al. Oct 1987 A
4756307 Crowninshield Jul 1988 A
4916207 Boyle, Jr. et al. Apr 1990 A
4938763 Dunn et al. Jul 1990 A
4950258 Kawai et al. Aug 1990 A
4968317 Tormala et al. Nov 1990 A
4990161 Kampner Feb 1991 A
5049591 Hayashi et al. Sep 1991 A
5053035 Mclaren Oct 1991 A
5061181 Niznick Oct 1991 A
5108289 Fukuyo Apr 1992 A
5108755 Daniels et al. Apr 1992 A
5110852 Gogolewski et al. May 1992 A
5192301 Kamiya et al. Mar 1993 A
5201771 Belykh et al. Apr 1993 A
5208305 Grootaert May 1993 A
5250584 Ikada et al. Oct 1993 A
5266608 Katz et al. Nov 1993 A
5275601 Gogolewski et al. Jan 1994 A
5294395 Broyer Mar 1994 A
5324308 Pierce Jun 1994 A
5333624 Tovey Aug 1994 A
5360448 Thramann Nov 1994 A
5364400 Rego, Jr. et al. Nov 1994 A
5376120 Sarver et al. Dec 1994 A
5383931 Hehli et al. Jan 1995 A
5407445 Tautvydas et al. Apr 1995 A
5417712 Whittaker et al. May 1995 A
5437918 Taniguchi et al. Aug 1995 A
5441515 Khosravi et al. Aug 1995 A
5458653 Davidson Oct 1995 A
5470334 Ross et al. Nov 1995 A
5525706 Gruber et al. Jun 1996 A
5527337 Stack et al. Jun 1996 A
5527341 Gogolewski et al. Jun 1996 A
5562704 Tamminmaki et al. Oct 1996 A
5567431 Vert et al. Oct 1996 A
5569250 Sarver et al. Oct 1996 A
5571193 Kampner Nov 1996 A
5571204 Nies Nov 1996 A
5633002 Stricker et al. May 1997 A
5634936 Linden et al. Jun 1997 A
5641502 Skalla et al. Jun 1997 A
5660846 Cheikh Aug 1997 A
5665831 Neuenschwander et al. Sep 1997 A
5670161 Healy et al. Sep 1997 A
5676699 Gogolewski et al. Oct 1997 A
5690671 McGurk et al. Nov 1997 A
5695497 Stahelin Dec 1997 A
5700901 Hurst et al. Dec 1997 A
5716410 Wang et al. Feb 1998 A
5716413 Walter et al. Feb 1998 A
5733330 Cox Mar 1998 A
5741329 Agrawal et al. Apr 1998 A
5760118 Sinclair et al. Jun 1998 A
5766239 Cox Jun 1998 A
5766618 Laurencin et al. Jun 1998 A
5792400 Talja et al. Aug 1998 A
5817328 Gresser et al. Oct 1998 A
5834582 Sinclair et al. Nov 1998 A
5837276 Cheikh Nov 1998 A
5853639 Kawakami et al. Dec 1998 A
5863297 Walter et al. Jan 1999 A
5868746 Sarver et al. Feb 1999 A
5893850 Cachia Apr 1999 A
5902599 Anseth et al. May 1999 A
5904658 Niederauer et al. May 1999 A
5908918 Chen et al. Jun 1999 A
5935172 Ochoa et al. Aug 1999 A
5939453 Heiler et al. Aug 1999 A
5947893 Agrawal et al. Sep 1999 A
5951288 Sawa Sep 1999 A
5968092 Buscemi et al. Oct 1999 A
5977204 Boyan et al. Nov 1999 A
5980564 Stinson Nov 1999 A
5997580 Mastrorio et al. Dec 1999 A
5997582 Weiss Dec 1999 A
6001100 Sherman et al. Dec 1999 A
6001101 Augagneur et al. Dec 1999 A
6005161 Brekke et al. Dec 1999 A
6071982 Wise et al. Jun 2000 A
6077989 Kandel et al. Jun 2000 A
6113624 Bezwada et al. Sep 2000 A
6136369 Leitao et al. Oct 2000 A
6150497 Sastry et al. Nov 2000 A
6156842 Hoenig et al. Dec 2000 A
6160084 Langer et al. Dec 2000 A
6162225 Gertzman et al. Dec 2000 A
6168570 Ferrera Jan 2001 B1
6179842 Spotorno et al. Jan 2001 B1
6203573 Walter et al. Mar 2001 B1
6206883 Tunc Mar 2001 B1
6248108 Tormala et al. Jun 2001 B1
6248430 Toyoda et al. Jun 2001 B1
6277390 Schaffner Aug 2001 B1
6281262 Shikinami Aug 2001 B1
6283973 Hubbard et al. Sep 2001 B1
6293950 Lynch et al. Sep 2001 B1
6299448 Zdrahala et al. Oct 2001 B1
6303697 Yuan et al. Oct 2001 B1
6315788 Roby Nov 2001 B1
6344496 Niederauer et al. Feb 2002 B1
6375465 Engman et al. Apr 2002 B1
6388043 Langer et al. May 2002 B1
6406498 Tormala et al. Jun 2002 B1
6425923 Stalcup et al. Jul 2002 B1
6436136 Flodin et al. Aug 2002 B1
6447515 Meldrum Sep 2002 B1
6468277 Justin et al. Oct 2002 B1
6486296 Shimamoto et al. Nov 2002 B1
6488938 Ogura et al. Dec 2002 B1
6503278 Pohjonen et al. Jan 2003 B1
6508830 Steiner Jan 2003 B2
6511511 Slivka et al. Jan 2003 B1
6514286 Leatherbury et al. Feb 2003 B1
6547792 Tsuji et al. Apr 2003 B1
6565606 Bruce et al. May 2003 B1
6579533 Tormala et al. Jun 2003 B1
6583232 Brown Jun 2003 B1
6599323 Meliean et al. Jul 2003 B2
6605090 Trieu et al. Aug 2003 B1
6613089 Estes et al. Sep 2003 B1
6623487 Goshert Sep 2003 B1
6652582 Stinson Nov 2003 B1
6716957 Tunc Apr 2004 B2
6719935 Tunc Apr 2004 B2
6720402 Langer et al. Apr 2004 B2
6726696 Houser et al. Apr 2004 B1
6758862 Berry et al. Jul 2004 B2
6758863 Estes et al. Jul 2004 B2
6783712 Slivka et al. Aug 2004 B2
6827743 Eisermann et al. Dec 2004 B2
6830575 Stenzel et al. Dec 2004 B2
6841111 Rickner et al. Jan 2005 B2
6843799 Bartlett Jan 2005 B2
6852825 Lendlein et al. Feb 2005 B2
6869445 Johnson Mar 2005 B1
6881766 Hain Apr 2005 B2
6902584 Kwan et al. Jun 2005 B2
6908466 Bonutti et al. Jun 2005 B1
6908624 Hossainy et al. Jun 2005 B2
6916321 TenHuisen et al. Jul 2005 B2
6951956 Yamane et al. Oct 2005 B2
6974862 Ringeisen et al. Dec 2005 B2
7012106 Yuan et al. Mar 2006 B2
7033603 Nelson et al. Apr 2006 B2
7192443 Solem et al. Mar 2007 B2
7208550 Mather et al. Apr 2007 B2
7214765 Ringeisen et al. May 2007 B2
7261716 Strobel et al. Aug 2007 B2
7261734 Gellman et al. Aug 2007 B2
7268205 Williams et al. Sep 2007 B2
7270813 Shimp et al. Sep 2007 B2
7285087 Moaddeb et al. Oct 2007 B2
7285130 Austin Oct 2007 B2
7314480 Eidenschink et al. Jan 2008 B2
7335375 Li et al. Feb 2008 B2
7378144 DeMeo et al. May 2008 B2
7455674 Rose Nov 2008 B2
7524891 Rose Apr 2009 B2
7553923 Williams et al. Jun 2009 B2
8501215 Chen et al. Aug 2013 B2
20010012940 Tunc Aug 2001 A1
20010018614 Bianchi Aug 2001 A1
20020022588 Wilkie et al. Feb 2002 A1
20020029041 Hover et al. Mar 2002 A1
20020029043 Ahrens et al. Mar 2002 A1
20020071822 Uhrich Jun 2002 A1
20020082362 Broccini et al. Jun 2002 A1
20020120348 Melican et al. Aug 2002 A1
20020138154 Li et al. Sep 2002 A1
20020143403 Vaidyanathan et al. Oct 2002 A1
20020150775 Ishikawa et al. Oct 2002 A1
20020160032 Long et al. Oct 2002 A1
20030045941 Lewallen Mar 2003 A1
20030055198 Langer et al. Mar 2003 A1
20030104031 Dumont et al. Jun 2003 A1
20030114937 Leatherbury et al. Jun 2003 A1
20030120280 Rolier et al. Jun 2003 A1
20030125745 Tseng et al. Jul 2003 A1
20030130742 Connelly et al. Jul 2003 A1
20030153971 Chandrasekaran Aug 2003 A1
20030153972 Helmus Aug 2003 A1
20030180344 Wise et al. Sep 2003 A1
20030236573 Evans et al. Dec 2003 A1
20040002770 King et al. Jan 2004 A1
20040015187 Lendlein et al. Jan 2004 A1
20040019386 Ferree Jan 2004 A1
20040030341 Aeschlimann et al. Feb 2004 A1
20040030342 Trieu et al. Feb 2004 A1
20040052992 Boone et al. Mar 2004 A1
20040054372 Corden et al. Mar 2004 A1
20040106734 Rose Jun 2004 A1
20040109823 Kaplan Jun 2004 A1
20040110285 Lendlein et al. Jun 2004 A1
20040115239 Shastri et al. Jun 2004 A1
20040131681 Ambrose et al. Jul 2004 A1
20040143221 Shadduck Jul 2004 A1
20040153075 Roger Aug 2004 A1
20040156878 Rezania et al. Aug 2004 A1
20040172118 Gibson Sep 2004 A1
20040193154 Leatherbury et al. Sep 2004 A1
20040241203 Shakesheff et al. Dec 2004 A1
20040242722 Rose Dec 2004 A1
20040254639 Li et al. Dec 2004 A1
20040258732 Shikinami Dec 2004 A1
20040259972 Ringeisen et al. Dec 2004 A1
20040260398 Kelman Dec 2004 A1
20040265385 West Dec 2004 A1
20040267263 May Dec 2004 A1
20050008672 Winterbottom et al. Jan 2005 A1
20050013793 Beckman et al. Jan 2005 A1
20050019404 Sung et al. Jan 2005 A1
20050033295 Wisnewski Feb 2005 A1
20050043751 Phan et al. Feb 2005 A1
20050043752 Phan et al. Feb 2005 A1
20050070928 Heino et al. Mar 2005 A1
20050080483 Solem et al. Apr 2005 A1
20050080489 Estes et al. Apr 2005 A1
20050085313 Nishitani Apr 2005 A1
20050085812 Sherman et al. Apr 2005 A1
20050090861 Porter Apr 2005 A1
20050107886 Crabtree et al. May 2005 A1
20050123582 Sung et al. Jun 2005 A1
20050125051 Eidenschink et al. Jun 2005 A1
20050136764 Sherman et al. Jun 2005 A1
20050137611 Escudero et al. Jun 2005 A1
20050137715 Phan et al. Jun 2005 A1
20050159812 Dinger, III et al. Jul 2005 A1
20050165128 Cohn et al. Jul 2005 A1
20050177144 Phan et al. Aug 2005 A1
20050177245 Leatherbury et al. Aug 2005 A1
20050182411 DeMeo et al. Aug 2005 A1
20050182428 Bearinger et al. Aug 2005 A1
20050187602 Eidenschink Aug 2005 A1
20050196420 Zucherman et al. Sep 2005 A1
20050197422 Mayadunne et al. Sep 2005 A1
20050208094 Armitage et al. Sep 2005 A1
20050209705 Niederauer et al. Sep 2005 A1
20050240281 Slivka et al. Oct 2005 A1
20050273106 Oepen Dec 2005 A1
20060051394 Moore et al. Mar 2006 A1
20060067973 Schachter Mar 2006 A1
20060095138 Truckai et al. May 2006 A1
20060121084 Borden et al. Jun 2006 A1
20060121087 Williams et al. Jun 2006 A1
20060136071 Maspero et al. Jun 2006 A1
20060149248 Schlienger et al. Jul 2006 A1
20060177480 Sung et al. Aug 2006 A1
20060178739 Shalaby et al. Aug 2006 A1
20060178748 Dinger, III et al. Aug 2006 A1
20060188546 Giroux Aug 2006 A1
20060188547 Bezwada Aug 2006 A1
20060200150 Iiomaki et al. Sep 2006 A1
20060207612 Jackson et al. Sep 2006 A1
20060247610 Lanphere et al. Nov 2006 A1
20060263335 France et al. Nov 2006 A1
20060264948 Williams Nov 2006 A1
20060293749 Hudgins et al. Dec 2006 A1
20070005094 Eaton et al. Jan 2007 A1
20070014831 Sung et al. Jan 2007 A1
20070041950 Leatherbury et al. Feb 2007 A1
20070043376 Leatherbury et al. Feb 2007 A1
20070043433 Chandrasekaran Feb 2007 A1
20070048383 Helmus Mar 2007 A1
20070050018 Wainwright Mar 2007 A1
20070065652 Liebschner Mar 2007 A1
20070067043 Dericks Mar 2007 A1
20070083205 Attawia et al. Apr 2007 A1
20070100449 O'Neil et al. May 2007 A1
20070128154 Hadba et al. Jun 2007 A1
20070134305 Zilberman Jun 2007 A1
20070141111 Suokas et al. Jun 2007 A1
20070156251 Karmon Jul 2007 A1
20070162019 Burns et al. Jul 2007 A1
20070182041 Rizk et al. Aug 2007 A1
20070191963 Winterbottom et al. Aug 2007 A1
20070213828 Trieu et al. Sep 2007 A1
20070260324 Joshi et al. Nov 2007 A1
20070265622 Aeschlimann et al. Nov 2007 A1
20070270852 Tormala et al. Nov 2007 A1
20070276366 Gaines, Jr. Nov 2007 A1
20070280983 Strickler et al. Dec 2007 A1
20070299151 Guelcher et al. Dec 2007 A1
20070299156 Brown Dec 2007 A1
20070299449 Allinniemi et al. Dec 2007 A1
20080015578 Erickson et al. Jan 2008 A1
20080077140 Osman Mar 2008 A1
20080085297 Dave et al. Apr 2008 A1
20080086199 Dave et al. Apr 2008 A1
20080109037 Steiner et al. May 2008 A1
20080154368 Justis et al. Jun 2008 A1
20080154373 Protopsaltis et al. Jun 2008 A1
20080200638 Redepenning Aug 2008 A1
20080206297 Roeder et al. Aug 2008 A1
20080228186 Gall et al. Sep 2008 A1
20080234754 McCarthy et al. Sep 2008 A1
20080234762 Forstein et al. Sep 2008 A1
20080241211 Han et al. Oct 2008 A1
20080249633 Wu Oct 2008 A1
20080262613 Gogolewski Oct 2008 A1
20080305144 Brown et al. Dec 2008 A1
20090030160 Kanazawa Jan 2009 A1
20090048145 Hellerbrand et al. Feb 2009 A1
20090093888 Dawson et al. Apr 2009 A1
20090099600 Moore et al. Apr 2009 A1
20090149856 Paakinaho et al. Jun 2009 A1
20090171064 Arimura et al. Jul 2009 A1
20090204116 Shalaby et al. Aug 2009 A1
20090270923 Tormala et al. Oct 2009 A1
20090274742 Brown Nov 2009 A1
20100136648 Balderas et al. Jun 2010 A1
Foreign Referenced Citations (138)
Number Date Country
2008240418 Apr 2008 AU
2008240418 Oct 2008 AU
2254002 May 2000 CA
1857742 Nov 2006 CN
1604403 Nov 1970 DE
2817778 Nov 1978 DE
2947985 Sep 1981 DE
3036611 Jun 1982 DE
3936188 May 1990 DE
4226465 Feb 1993 DE
4220216 Jan 1994 DE
102005032005 Jan 2007 DE
204931 Dec 1986 EP
299004 Jan 1989 EP
321389 Jun 1989 EP
326426 Aug 1989 EP
401844 Dec 1990 EP
404004 Dec 1990 EP
439892 Aug 1991 EP
475077 Mar 1992 EP
590656 Apr 1994 EP
595956 May 1994 EP
326426 Dec 1994 EP
635274 Jan 1995 EP
531487 Jan 1996 EP
711534 May 1996 EP
747072 Dec 1996 EP
751165 Jan 1997 EP
803521 Oct 1997 EP
805175 Nov 1997 EP
806283 Nov 1997 EP
1000958 May 2000 EP
1009448 Jun 2000 EP
1056487 Dec 2000 EP
1086711 Mar 2001 EP
1136510 Sep 2001 EP
1142597 Oct 2001 EP
1093774 Jun 2002 EP
1216717 Jun 2002 EP
1277482 Jan 2003 EP
815809 Mar 2004 EP
1284756 Sep 2004 EP
2691901 Oct 1993 FR
2691901 Dec 1993 FR
2863478 Jun 2005 FR
807589 Jan 1959 GB
1416575 Dec 1975 GB
2215209 Sep 1989 GB
62-199429 Sep 1987 JP
01-192367 Aug 1989 JP
2169612 Jun 1990 JP
02-270519 Nov 1990 JP
03-021613 Jan 1991 JP
05-147105 Jun 1993 JP
06-065460 Mar 1994 JP
06-234157 Aug 1994 JP
8196617 Aug 1996 JP
9040761 Feb 1997 JP
9095606 Apr 1997 JP
9221539 Aug 1997 JP
9234241 Sep 1997 JP
9272790 Oct 1997 JP
10176039 Jun 1998 JP
10309313 Nov 1998 JP
11209595 Aug 1999 JP
2003-094516 Apr 2003 JP
2003-518230 Jun 2003 JP
3503045 Mar 2004 JP
2006-503172 Jan 2006 JP
2007046050 Feb 2007 JP
0180858 Apr 1999 KR
8404311 Nov 1984 WO
9003768 Apr 1990 WO
9301773 Feb 1993 WO
9534331 Dec 1995 WO
9622061 Jul 1996 WO
9705193 Feb 1997 WO
9725936 Jul 1997 WO
9729673 Aug 1997 WO
9736555 Oct 1997 WO
9800141 Jan 1998 WO
9826814 Jun 1998 WO
9830141 Jul 1998 WO
9847445 Oct 1998 WO
9911296 Mar 1999 WO
9911297 Mar 1999 WO
9922770 May 1999 WO
0001426 Jan 2000 WO
0056376 Sep 2000 WO
0056376 Sep 2000 WO
0146501 Jun 2001 WO
0196105 Dec 2001 WO
0200137 Jan 2002 WO
0234159 May 2002 WO
0234310 May 2002 WO
02076725 Oct 2002 WO
03004071 Jan 2003 WO
03064531 Aug 2003 WO
2004011054 Feb 2004 WO
2004071356 Aug 2004 WO
2004110313 Dec 2004 WO
2005014718 Feb 2005 WO
2005028534 Mar 2005 WO
2005046470 May 2005 WO
2005085313 Sep 2005 WO
2005112804 Dec 2005 WO
2006053936 May 2006 WO
2006064025 Jun 2006 WO
2006095138 Sep 2006 WO
2006108114 Oct 2006 WO
2006114483 Nov 2006 WO
2006116129 Jan 2007 WO
2007020430 Feb 2007 WO
2007020432 Feb 2007 WO
2007021593 Feb 2007 WO
2007023296 Mar 2007 WO
2007024492 Mar 2007 WO
WO2007038009 Apr 2007 WO
2007065074 Jun 2007 WO
2007084609 Jul 2007 WO
2007086832 Aug 2007 WO
2007111808 Oct 2007 WO
2007117499 Oct 2007 WO
2008001633 Jan 2008 WO
2008004011 Jan 2008 WO
2008116591 Mar 2008 WO
2008044011 Apr 2008 WO
2008067531 Jun 2008 WO
2008067561 Jun 2008 WO
2008089172 Jul 2008 WO
2008098019 Aug 2008 WO
2008101932 Aug 2008 WO
2008112875 Sep 2008 WO
2008112880 Sep 2008 WO
2008112912 Sep 2008 WO
2008131197 Oct 2008 WO
2008134264 Nov 2008 WO
03004071 Jan 2013 WO
Non-Patent Literature Citations (82)
Entry
International Search Report and Written Opinion for PCT/US2008/060401 Dated Jan. 9, 2009.
Zegzula, et al., ‘Bone Formation with Use of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2,’ The Journal of Bone and Joint Surgery, 79:1778-1790 (1997).
Zhang, Biodegradable lactide polymers: synthesis, degradation, and controlled drug release properties (drug release), Queen's University at Kingston, Canada, vol. 55/01-B of Dissertation Abstracts International, p. i-xv, 1-179 (Oct. 1993).
English Translation of Japanese Office Action dated Jun. 19, 2012 for JP Application 2010-504182. p. 1-6.
First Office Action for Patent Application No. JP 2010-504201, mail-dated Mar. 19, 2013, 5 pages.
Ofer Nativ, et al., “Bladder Neck Suspension Using Bone Anchors for the Treatment of Female Stress Incontinence,” ASAIO Journal, vol. 43 No. 3, pp. 204-208 and cover, May-Jun. 1997, 6 pages.
Mitsura Momma, et al., “Long Bone Intramedullary Fixation Method Using Shape Memory Anchoring Nails—An Attempt at a Biomechanical Test and the Application Thereof to Proximal Humeral Fractures,” Journal of the Eastern Japan Association of Orthopaedics and Traumatology, vol. 12, No. 4, pp. 385-390 and back cover, 2000, 8 pages.
Notice of Reasons for Rejection for Japanese Patent Application No. 2010-504201 dated Nov. 26, 2013, 10 pages and English translation thereof.
Andriano, et al., ‘Processing and characterization of absorbable polylactide polymers for use in surgical implants,’ Journal of Applied Biomaterials, 5(2):133-140 (1994).
Asano, et al., ‘In vivo characteristics of low molecular weight copoly(D.L-lactic acid) formulations with controlled release of LH-RH agonist,’ Biomaterials, 10(8):569-573 (1989).
Barca, et al., ‘Resorbable poly-L-lactic acid mini-staples for the fixation of Akin osteotomies,’ The Journal of Foot and Ankle Surgery, 36(2):106-111 (1997).
Bartenev et al.; On the theory of biaxial orientation of amorphous polymers, Mechanics of Composite Materials, 1973, vol. 6, p. 671-677.
Bertrand, et al., Biocompatibility Aspects of New Stent Technology, JACC, 32(3):562-571 (1998).
Celikkaya, et al., ‘Poly(DL-lactide)/Poly(ethylene glycol) Copolymer Particles. I. Preparation and Characterization,’ Journal of Applied Polymer Science, 61: 1439-1446 (1996).
D. Hull and T. W. Clyne, ‘An introduction to composite materials,’ Second Edition, Cambridge University Press, Table of Contents, (1996) 8 pages.
D. Wheeler, et al., ‘Effect of bioactive glass particle size on osseous regeneration of cancellous defects,’ J. Biomed. Materials Research, 41(4):527-533 (1998).
Daniels, et al., ‘Mechanical properties of biodegradable polymers and composites proposed for internal fixation of bone,’ J. Applied Biomaterials, 1 :57-78 (1990).
Dauner, et al. ‘Resorbable continuous-fiber reinforced polymers for osteosynthesis,’ J. Materials Science Materials in Medicine, 9: 173-179 (1998).
Eling, et al., ‘Biodegradable Materials of Poly(L-Lactic Acid): 1. Melt-Spun and Solution-Spun Fibres,’ Polymer, 23:1587-1593 (1982).
Fambri, et al., ‘Biodegradable fibres of poly(I-lactic acid) produced by melt spinning,’ Polymer, 38:79-85 (1997).
Frenger, ‘Biomedical Uses of Shape Memory Polymers,’ Biomed. Sci. Instrum., 29:47-50 (1993).
Fukuzaki, et al., Synthesis of copoly(D,L-Lactic acid) with relatively low molecular weight and in vitro degradation, Japan Atomic Energy Research Institute, Gunma, Jpn, European Polymer Journa1,25(10):1019-1026 (1989).
Gautier, et al., ‘Poly(a-hydroxyacids) for application in the spinal cord: Resorbability and biocompatibility with adult rate Schwann cells and spinal cord,’ Journal of Biomedical Materials Research, 42(4):642-654 (1998).
Giardina, et al., ‘Experimental evaluation of a resorbable intramedullary plug for cemented total hip replacement,’ Biomaterials, 18(13):907-913 (1997).
Gogolewsji, et al., ‘Resorbable materials of poly(L-lactide). II Fibers spun from solutions of poly(L-lactide) in good solvents,’ J. Appl. Polymer Sci., 28:1045-1061 (1983).
Grijpma et al., ‘Chain Entanglement Mechanical Properties and Drawability of Poly (Lactide),’ Colloid Polym Sci., 272:1068-1081 (1994).
Haers, et al., ‘Biodegradable polyactide plates and screws in orthognathic surgery,’ Technical Note, Journal of Cranio-Maxillofacial Surgery, 26(2):87-91 (1998).
Hyon, et al., ‘Effects of residual monomer on the degradation of DL-lactide polymer,’ Hyon, Jamshidi & Ikada, Polymer International, 46:196-202 (1998).
J. West et al, ‘Bioactive Polymers, Synthetic biodegradable polymer scaffolds,’ Chapter 5, pp. 83-95, Anthony Atala and David J. Mooney, Editors; Joseph P. Vacanti and Robert Langer, Associate Editors, Birkhauser (1997).
Kaitian, et al., ‘Poly(D,L-Lactic Acid) Homopolymers: Synthesis and Characterization,’ Turkish Journal of Chemistry, 20:43-53 (1996).
Kister, et al., ‘Effects of morphology, conformation and configuration on the IR and Raman spectra of various poly(lactic acid)s,’ Polymer, 39(2): 267-273 (1998).
Koelling, et al., ‘In vitro real-time aging and characterization of poly(L/D-lactic acid),’ Proceedings of the 1997 1ffh Southern Biomedical Engineering Conference (Cat. No. 97TH8270), pp. 197-201.
Kontio, et al., ‘Fibrous wound repair associated with biodegradable poly-L/D-lactide copolymers implants: study of the expression of tenascin and cellular fibronectin,’ Journal of Materials Science-Materials in Medicine, 9:10:603-609 (1988).
Kricheldorf, et al., ‘Polyactones: 32. High-molecular weight polylactides by ring-opening polymerization with dibutylmagnesium or butylmagnesium chloride,’ Polymer, 36(15):2995-3003 (1995).
L. L. Hench, ‘Bioactive materials: The potential for tissue regeneration,’ J. Biomed. Materials Research, 41(4):511-518 (1998).
Losken, et al., ‘Memory of DL-polylactic acid biodegradable plates,’ Ann. Plast. Surg., 32(6):606-611 (1994).
MacDonald, et al., ‘Enzymatic degradability of poly(lactide): Effects of chain stereochemistry and material crystallinity,’ Macromolecules, 29(23):7356-7361 (1996).
Mainil-Varlet, et al., ‘Effect of in vivo and in vitro degradation on molecular and mechanical properties of various low-molecular weight polylactides,’ Journal of Biomedical Materials Research, 36(3):360-380 (1997).
Matsumura, et al., ‘Novel ring opening polymerization of lactide by lipase,’ Macromol. Symp., 130:285-304 (1998).
Mauduit, J. et al.; “Hydrolytic degradation of films prepared from blends of high and low molecular weight poly (DL lactic acid)s” Journal of Biomedical Materials Research, 1996, vol. 30, p. 201-207.
Morita, et al., ‘Intravitreous delivery of dexamethasone sodium m-sulfobenzoate from poly(DL-lactic acid) implants,’ Biological & Pharmaceutical Bulletin, 21 (2): 188-190 (1998).
Okihara, et al., Crystal structure of stereocomplex of poly(L-lactide) and poly(D-lactide), Journal of Macromolecular Science-Physics, B30(1 and 2): 119-140 (1991).
Okuzaki, et al., Mechanical Properties and Structure of the Zone-Drawn Poly(l-lactic acid) Fibers, Journal of Polymer Science, Part B, Polymer Physics, 37:991-996 (1999).
Oriented Polymer Materials, Edited by Stoyko Fakirov, published by Huthig & Wepf Verlag Zug, Heidelberg, Oxford CTIUSA, Table of Contents pp. v, viii, ix-xix (1996).
Penning, et al., ‘Preparation and properties of absorbable fibres from I-lactide copolymers,’ Polymer, 34(5):942-951 (1993).
Pitt, et al., ‘Modification of the rates of chain cleavage of polY(e-caprolactone) and related polyesters in the solid state,’ Journal of Controlled Release, 4:283-292 (1987).
Pitta, et al., “Comparison of fixation of the femoral component without cement and fixation with use of a bone-vacuum cementing technique for the prevention of fat embolism during total hip arthroplasty,” J. Bone Joint Surg., 81-A(6)-831-843 (1999).
Rak, et al., ‘The preparation and characterization of poly(D,L-lactic acid) for use as a biodegradable drug carrier,’ (1985) liverpool Poly tech., liverpool, UK, Pharmaceutica Acta Helvetiae, 60:(5-6):162-169.
Ristic, et al., ‘An investigation of synthesis and degradation of poly(D,L-lactide) and controlled release of albumin from biodegradable poly(D,L-lactide) cylinders,’ ICheaP-2, the second Italian conference on chemical and process engineering, Florence, pp. 559-563 (1995).
Schliephake, et al., ‘Reconstruction of the mandible by prefabricated autogenous bone grafts,’ Int. J. Oral Maxillofac. Surg., 26:244-252 (1997).
Stahelin, et al., Clinical degradation and biocompatibility of different bioabsorbable interference screws: a report of six cases: Arthroscopy: The Journal of Arthroscopic & Related Surgery, 13(2):238-244 (1997).
Steendam, et al., The role of elastic relaxation in drug delivery from poly(DL-lactic acid) based tablets. A shape memory phenomenon: Proceedings of the International Symposium on Controlled Release of Bioactive Materials, 25:128-129 (1998).
Stevels, et al., ‘Blends van blok copolymeren die een poly(L-lactide) of poly(D-lactide) blok bevatten,’ Biomedical Science and Engineering Meeting, pp. 107-110 (1994).
Structure and Properties of Oriented Polymers, Ed. I. M. Ward, Department of Physics, UniverSity of Leads, England, a Halsted Press Book, John Wiley & Sons, New York-Toronto (1975) Table of Contents.
Tagl, “Thesis—The morselized and impacted bone graft animal experiments on proteins, impaction and load,” Acta Orthop. Scand. Suppl., 290:1-40 (2000).
Temenoff et al., “Injectable biodegradable materials for orthopedic tissue engineering,” Biomaterials, 21 :2405-2412 (2002).
Tschakaloff, et al., ‘Degradation kinetics of biodegradable DL-polyactic acid biodegradable implants depending on the site of implantation,’ International Journal of Oral and Maxillofacial Surgery, 23(6 Pt2 ):443-445 (1994).
Tsuji, et al., Stereocomplex formation between enantiomeric poly(lactic acid). VIII. Complex fibers spun from mixed solution of poly(D-lactic acid) and poly(L-lactic acid), Journal of Applied Polymer Science, 51(2):337-344 (1994).
Chart BMEN 343 Polymer Tg Chart.
Examination Report for counterpart Australian Application No. 2008242737 dated Aug. 10, 2012, 3 pages.
First Office Action for Japanese Application No. 2010-503579 dated Mar. 6, 2012, 6 pages.
International Preliminary Report on Patentability and Written Opinion for PCT Application No. PCT/GB2008/001331 dated Oct. 20, 2009, 8 pages.
International Search Report and Written Opinion for PCT/GB2008/001331 dated Aug. 25, 2008.
Office Action for Australian Patent Application No. 2008240418 dated Dec. 2, 2011.
Office Action for Japanese Application No. 2010504268 dated Jan. 8, 2013, 4 pages.
Office Action for Japanese Application No. 2010504268 dated Jul. 17, 2012, 6 pages.
Second Office Action for Japanese Application No. 2010-503579 dated Feb. 19, 2013, 3 pages.
Summary of Office Action, dated Mar. 19, 2012, 1 page.
Water Transport in Polylactic Acid (PLA), Siparsky et al. Journal of Environmental Polymer Degradation, vol. 5, No. 3, 1997.
International Preliminary Report on Patentability and Written Opinion for PCT/GB2012/052478 dated Apr. 8, 2014, 14 pages.
International Search Report for PCT Application No. PCT/GB2012/052478, dated Jun. 20, 2013, 6 pages.
International Preliminary Report on Patentability and Written Opinion for PCT/GB2012/052470 dated Apr. 8, 2014, 6 pages.
International Search Report for PCT Application No. PCT/GB2012/052470 dated Feb. 22, 2013, 2 pages.
International Search Report for PCT Application No. PCT/GB2012/052475 dated Mar. 8, 2013, 3 pages.
International Preliminary Report on Patentability and Written Opinion for PCT Application No. PCT/GB2012/052475 dated Apr. 8, 2014, 10 pages.
International Preliminary Report on Patentability and Written Opinion for PCT Application No. PCT/GB2012/052480 dated Apr. 8, 2014, 12 pages.
International Search Report for PCT Application No. PCT/GB2012/052480 dated May 31, 2013, 4 pages.
Decision of Rejection for Japanese Patent Application No. 2010-504201 dated Jun. 2, 2014, 6 pages.
Song, K. et al. “Double bubble tubular film extrusion of polybutylene terephthalate—polyethylene terephthalate blends.” Publication of Society of Plastic Engineers, Dec. 1999.
Atkins, G.J. et al. “Role of polyethylene particles in peri-prosthetic osteolysis: A Review.” World of Journals of Orthopedics, 2(10), Oct. 18, 2011, pp. 93-101.
Hill, R.G., “Chapter 10: Biomedical Polymers.” Biomaterials, artificial organs and tissue engineering. Imperial College London, UK (2005), 7 pages.
Vert, M. et al. “Bioresorbability and biocompatibility of aliphatic polyesters”, Journal of Materials Science: Materials in Medicine 3, 1992, pp. 432-446.
Related Publications (1)
Number Date Country
20100145448 A1 Jun 2010 US
Provisional Applications (1)
Number Date Country
60912828 Apr 2007 US